Integrated cancer biotech Infinitopes secures £12.8m seed financing to enhance its Precision Immunomics™ antigen discovery technologies to target five more cancers May 2, 2024 — 07:01
Selected for oral presentation! Kelun-Biotech to announce latest clinical study results of SKB264 (MK-2870, TROP2-ADC) for treatment of HR+/HER2- breast cancer at ESMO Congress 2023 August 1, 2023 — 21:07
Gracell Biotechnologies Presents Updated Data of Deep and Durable Responses for FasTCAR-T GC012F in Relapsed/Refractory Multiple Myeloma at 2023 ASCO Annual Meeting June 4, 2023 — 02:15
Gracell Biotechnologies Announces FDA Clearance of the IND Application for Phase 1b/2 Clinical Trial of FasTCAR-T GC012F for the Treatment of Relapsed/Refractory Multiple Myeloma February 3, 2023 — 20:30
ReLive Biotechnologies, Ltd. Completes Asset Purchase of Co.Don AG and Series A Financing Led By SHC, Furthering its Ambition to Become the Global Leader in Regenerative Therapies January 26, 2023 — 12:11
Gracell Biotechnologies Presents Clinical Data for FasTCAR-T GC012F for High Risk, Newly Diagnosed Multiple Myeloma Demonstrating 100% Overall Response Rate December 11, 2022 — 07:15
Gracell Biotechnologies to Present Data at AACR Annual Meeting 2022 Showcasing Early First-in-Human Results for GC502 in r/r B-ALL April 9, 2022 — 04:00
KeyZell start-up plans to reach 5 million euros in private investment and become the new biotech unicorn March 17, 2022 — 15:30
Gracell Biotechnologies Announces Details of Poster Presentation at AACR Annual Meeting 2022 March 9, 2022 — 05:30
Gracell Biotechnologies Doses First Patients in First-in-Human Clinical Trial Evaluating GC012F, its Dual-Targeting FasTCAR-T Therapy, in B-Cell Non-Hodgkin’s Lymphoma February 17, 2022 — 21:30
Genetech Biotechnology Launches Four Exclusive Promo Bundles For Citrea In Celebration Of Chinese New Year January 18, 2022 — 15:16
Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agreement for Clinically Validated BCMA CAR Construct January 11, 2022 — 05:30
Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agreement for Clinically Validated BCMA CAR Construct January 11, 2022 — 05:30
GenScript ProBio, Abogen Biosciences and Walvax Biotechnology Enter into Collaboration on BLA and Commercial Manufacturing of mRNA Vaccine November 30, 2021 — 10:39
Happiness Biotech Announced The Launch of Its Lucidum Tablets on DouYin Mall September 10, 2021 — 20:00
Podcasts China Money Podcast: China’s Electric Vehicle, Biotech And A.I. Sectors Win New VC Funding August 20, 2021 — 23:50
HebaBiz Biotech’s anti-cancer drug candidate under development Siroquine (JP001) has been approved for IND clinical trials in the United States August 20, 2021 — 19:45
Within weeks of first COVID-19 outbreak, China’s Qingdao Weida Biotechnology had switched all production capability over to PPE July 20, 2021 — 07:15
Happiness Biotech Launched Beta Version Of Happy Buy International, Promoting Cross-border E-Commerce SaaS Services June 18, 2021 — 22:30
Podcasts China Money Podcast: Robotics, Biotech And Electric Vehicle Startups Clear Funding Hurdles April 16, 2021 — 23:50
Gracell Biotechnologies Reports Long-term Follow-up Data on TruUCAR-enabled GC027 in Relapsed/Refractory T-ALL at the AACR 2021 Annual Meeting April 10, 2021 — 21:33
Evive Biotech Submits Biologics License Application to US FDA for Ryzneuta(TM) March 31, 2021 — 11:26
Gracell Biotechnologies Receives Medical Products Manufacturing Certificate for CAR-T Cell Therapy Products January 15, 2021 — 21:00
Tech China Tech Digest: Biotech Firms Rush To List In China, Huawei Debuts Low Price Lidar December 23, 2020 — 08:08
Accelerating Innovation, Deepening Integration | Viva Biotech Online Investor Day Review December 14, 2020 — 12:15
